TachoSil - A Randomized, Open-Label, Parallel-Group, Multi-Center Trial to Compare Efficacy and Safety of TachoSil versus Surgicel Original for the Secondary Hemostatic Treatment of Needle Hole Bleeding in Vascular Surgery

Grants and Contracts Details

StatusFinished
Effective start/end date3/19/12 → 8/31/16

Funding

  • Nycomed Amersham Inc: $116,761.00